A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.
Browsing Category

COVID-19

One Antibody Trial Is Halted, While Others Continue

An ongoing trial of the antibody bamlanivimab—administered with remdesivir, an antiviral medication—on hospitalized COVID-19 patients has been halted by bamlanivimab’s manufacturer Eli Lilly. The decision was made to stop the trial after…

COVID-19 Death Rates Drop Among Hospitalized Patients

Two peer-reviewed studies demonstrate a decrease in deaths among hospitalized patients with COVID-19 across the board, including older adults and those with comorbidities. One study looked at 5,000 hospitalized COVID-19 patients in New York…

Remdesivir Approved as First COVID-19 Treatment

The U.S. Food and Drug Administration (FDA) has approved the antiviral drug remdesivir (brand name Veklury, Gilead Sciences) for treating patients hospitalized with COVID-19. This is the first treatment for COVID-19 to receive FDA approval.…

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy